CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery [clinicaltrials:NCT00635245]
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery [clinicaltrials:NCT00635245]
Bio2RDF identifier
NCT00635245
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00635245
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Monoclonal a ...... at can be removed by surgery.
brief title [clinicaltrials_vocabulary:brief-title]
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Primary
- To ...... ill be followed for 5 months.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2008-03-12T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
stage IA breast cancer
stage IB breast cancer
stage II breast cancer
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-03-10T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00635245
official title [clinicaltrials_vocabulary:official-title]
A Phase 1 Pharmacodynamic Stud ...... atment For Early Breast Cancer
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
P30CA077598
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2015-03-01T00:00:00Z
identifier
clinicaltrials:NCT00635245
title
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
@en
type
label
CP-751871 In Treating Women Wi ...... y [clinicaltrials:NCT00635245]
@en